机构：[1]College of Life Science and Technology, Beijing University of Chemical Technology, Beijing 100029, China[2]Institute of Cerebrovascular Disease Research and Department of Neurology, Xuanwu Hospital of Capital Medical University, Beijing, China神经科系统神经内科首都医科大学宣武医院
Key Project of Beijing University of Chemical Technology [XK1803-06]; National Key Research and Development Program of China [2018YFA0903000, 2020YFC2005405, 2020YFA0712100, 2020YFC0840805]; Funds for First-class Discipline Construction [XK1805]; Inner Mongolia Key Research and Development Program [2019ZD006]; National Natural Science Foundation of China [81672001, 81621005]; NSFC-MFST project (China-Mongolia) [31961143024]; Fundamental Research Funds for Central Universities [BUCTRC201917, BUCTZY2022]
第一作者机构：[1]College of Life Science and Technology, Beijing University of Chemical Technology, Beijing 100029, China
共同第一作者：
通讯作者：
推荐引用方式(GB/T 7714)：
Fan Huahao,Lou Fuxing,Fan Junfen,et al.The emergence of powerful oral anti-COVID-19 drugs in the post-vaccine era[J].LANCET MICROBE.2022,3(2):E91-E91.doi:10.1016/S2666-5247(21)00278-0.
APA：
Fan, Huahao,Lou, Fuxing,Fan, Junfen,Li, Maochen&Tong, Yigang.(2022).The emergence of powerful oral anti-COVID-19 drugs in the post-vaccine era.LANCET MICROBE,3,(2)
MLA：
Fan, Huahao,et al."The emergence of powerful oral anti-COVID-19 drugs in the post-vaccine era".LANCET MICROBE 3..2(2022):E91-E91
生物学